[HTML] plos.org

[HTML][HTML] Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in COVID-19 critically ill patients: An observational prospective study

G Montrucchio, G Sales, F Rumbolo, F Palmesino… - PLoS …, 2021 - journals.plos.org
Objective To test the effectiveness of mid-regional pro-adrenomedullin (MR-proADM) in
comparison to C-reactive protein (CRP), procalcitonin (PCT), D-dimer, lactate …
被引用次数：51 相关文章

Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in COVID-19 critically ill patients: An observational prospective study

G Montrucchio, G Sales, F Rumbolo… - PloS …, 2021 - pubmed.ncbi.nlm.nih.gov
Objective To test the effectiveness of mid-regional pro-adrenomedullin (MR-proADM) in
comparison to C-reactive protein (CRP), procalcitonin (PCT), D-dimer, lactate …
[PDF] archive.org

[PDF][PDF] Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in COVID-19 critically ill patients: An observational prospective study

G Montrucchio, G Sales, F Rumbolo, F Palmesino… - PLoS ONE, 2021 - scholar.archive.org
Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in
COVID-19 critically ill patients: An observ Page 1 RESEARCH ARTICLE Effectiveness of mid-regional …
[PDF] scienceopen.com

[PDF][PDF] Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in COVID-19 critically ill patients: An observational prospective study

G Montrucchio, G Sales, F Rumbolo, F Palmesino… - PLoS ONE, 2021 - scienceopen.com
Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in
COVID-19 critically ill patients: An observ Page 1 RESEARCH ARTICLE Effectiveness of mid-regional …

Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in COVID-19 critically ill patients: An observational prospective study

G Montrucchio, G Sales, F Rumbolo, F Palmesino… - PLOS ONE, 2021 - cir.nii.ac.jp
抄録< jats: sec id=" sec001">< jats: title> Objective</jats: title>< jats: p> To test the
effectiveness of mid-regional pro-adrenomedullin (MR-proADM) in comparison to C-reactive …
[PDF] core.ac.uk

[PDF][PDF] Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in COVID-19 critically ill patients: An observational prospective study

G Montrucchio, G Sales, F Rumbolo, F Palmesino… - PLoS ONE, 2021 - core.ac.uk
Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in
COVID-19 critically ill patients: An observ Page 1 RESEARCH ARTICLE Effectiveness of mid-regional …
[HTML] europepmc.org

[HTML][HTML] Effectiveness of Mid-Regional Pro-Adrenomedullin (MR-proADM) as Prognostic Marker in COVID-19 Critically Ill Patients: an Observational Prospective Study

G Montrucchio, G Sales, F Rumbolo, F Palmesino… - 2020 - europepmc.org
Background: Due to the lack of validated biomarkers to predict disease progression and
mortality in COVID-19 ICU-patients, we tested the effectiveness of mid-regional pro …

Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in COVID-19 critically ill patients: An observational prospective study

G Montrucchio, G Sales, F Rumbolo, F Palmesino… - PLOS ONE, 2021 - iris.unito.it
Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in
COVID-19 critically ill patients: An observ Page 1 RESEARCH ARTICLE Effectiveness of mid-regional …

[引用][C] Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in COVID-19 critically ill patients: An observational prospective study

G Montrucchio, G Sales, F Rumbolo… - PLoS …, 2021 - ui.adsabs.harvard.edu
Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in
COVID-19 critically ill patients: An observational prospective study - NASA/ADS Now on …

Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in COVID-19 critically ill patients: An observational prospective study

G Montrucchio, G Sales, F Rumbolo, F Palmesino… - PLoS ONE, 2021 - go.gale.com
Objective To test the effectiveness of mid-regional pro-adrenomedullin (MR-proADM) in
comparison to C-reactive protein (CRP), procalcitonin (PCT), D-dimer, lactate …